- Home
- AREC vs CABA Comparison
AREC vs CABA Comparison
Compare AREC & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREC
- CABA
- Stock Information
- Founded
- AREC 2013
- CABA 2017
- Country
- AREC United States
- CABA United States
- Employees
- AREC N/A
- CABA N/A
- Industry
- AREC Coal Mining
- CABA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AREC Energy
- CABA Health Care
- Exchange
- AREC Nasdaq
- CABA Nasdaq
- Market Cap
- AREC 235.2M
- CABA 200.3M
- IPO Year
- AREC 2019
- CABA 2019
- Fundamental
- Price
- AREC $3.91
- CABA $2.36
- Analyst Decision
- AREC Strong Buy
- CABA Strong Buy
- Analyst Count
- AREC 3
- CABA 8
- Target Price
- AREC $4.67
- CABA $12.75
- AVG Volume (30 Days)
- AREC 4.5M
- CABA 2.5M
- Earning Date
- AREC 11-13-2025
- CABA 11-13-2025
- Dividend Yield
- AREC N/A
- CABA N/A
- EPS Growth
- AREC N/A
- CABA N/A
- EPS
- AREC N/A
- CABA N/A
- Revenue
- AREC $330,304.00
- CABA N/A
- Revenue This Year
- AREC N/A
- CABA N/A
- Revenue Next Year
- AREC N/A
- CABA N/A
- P/E Ratio
- AREC N/A
- CABA N/A
- Revenue Growth
- AREC N/A
- CABA N/A
- 52 Week Low
- AREC $0.38
- CABA $0.99
- 52 Week High
- AREC $4.36
- CABA $5.46
- Technical
- Relative Strength Index (RSI)
- AREC 74.19
- CABA 61.71
- Support Level
- AREC $2.61
- CABA $2.24
- Resistance Level
- AREC $3.33
- CABA $2.59
- Average True Range (ATR)
- AREC 0.36
- CABA 0.20
- MACD
- AREC 0.09
- CABA 0.00
- Stochastic Oscillator
- AREC 77.78
- CABA 66.28
About AREC American Resources Corporation
American Resources Corp constructs and/or purchases and manages a chain of combined gasoline, diesel and natural gas (NG) fueling and service stations; construct conversion factories to convert NG to liquefied natural gas (LNG) and compressed natural gas (CNG); and construct conversion factories to retrofit vehicles currently using gasoline or diesel fuel to also run on NG in the United States and also to build a convenience store to serve its customers in each of its locations. Its segments are AIC focused on the extraction, processing, transportation, and distribution of coal for a variety of industries, with a focus on metallurgical quality coal to the steel industry; RLMT; and EMC.
About CABA Cabaletta Bio Inc.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.